Facebook-f X-twitter Youtube Linkedin-in
Home Safety Alert Bedaquiline-containing regimenscardiac adverse events

Bedaquiline-containing regimenscardiac adverse events

Bedaquiline-containing regimenscardiac adverse events

Bedaquiline is an antimycobacterial drug used for the treatment of pulmonary multidrug resistant tuberculosis.
Bedaquiline inhibits adenosine 5′-triphosphate (ATP) synthesis, a process that is crucial to the growth of mycobacterium
and to its survival in its non-growing dormant state. Bedaquiline is recommended for the treatment of pulmonary
Multidrug Resistant Tuberculosis (MDR-TB) and Rifampicin Resistant-Tuberculosis medicines (RR-TB) by world health
organization. Bedaquiline is used in Botswana for management of MDR-TB and RR-TB.

Badaquilene Containing Regimens Cardiac Adverse Events Safety AlertDownload
Facebook-f X-twitter Youtube Linkedin-in

Social Media

More Posts

No spam, notifications only about new products, updates.

Most vaccines are safe and well tolerated. However, if you experience any discomfort after vaccination, seek immediate medical attention and ask your healthcare provider to report the event to BoMRA

Botswana Medicines Regulatory Authority
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.